Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1034
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
-8.46M
-
Total reported value, excl. options
-
$31.3B
-
Value change
-
-$2.35B
-
Put/Call ratio
-
1.78
-
Number of buys
-
410
-
Number of sells
-
-547
-
Price
-
$267.55
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q2 2020
1,237 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q2 2020.
BIOGEN INC. - Common Stock (BIIB) has 1,034 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
of 147M outstanding shares and own 79.61% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.6M shares), VANGUARD GROUP INC (12.9M shares), STATE STREET CORP (7.84M shares), WELLINGTON MANAGEMENT GROUP LLP (4.77M shares), Clearbridge Investments, LLC (4.08M shares), RENAISSANCE TECHNOLOGIES LLC (3.91M shares), GEODE CAPITAL MANAGEMENT, LLC (3.04M shares), NORTHERN TRUST CORP (2.44M shares), Bank of New York Mellon Corp (2.32M shares), and AQR CAPITAL MANAGEMENT LLC (2.24M shares).
This table shows the top 1034 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.